| KRT setting | PD target†| MCS-driven Cefepime dosing recommendation | Probability of total concentration above neurotoxicity threshold at the end of each day during 1 week of therapy£ | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Day 1 | Day 2 | Day 3 | Day 4 | Day 5 | Day 6 | Day 7 | ||||
1 | 4-hour HD on Mon-Wed-Fri | 60% fT > MIC | 2 g LD, 1 g q24h post-HD | 58.5% | 10.0% | 41.9% | 10.7% | 41.2% | 51.9% | 16.6% |
60% fT > MICx4 | 3 g LD, 2 g q12h post-HD | 98.2% | 84.7% | 98.3% | 85.1% | 98.3% | 98.4% | 85.5% | ||
2 | 4-hour HD daily | 60% fT > MIC | 2 g LD, 1 g q24h post-HD | 1.9% | 1.1% | 1.1% | 1.2% | 1.3% | 1.5% | 1.5% |
60% fT > MICx4 | 3 g LD, 2 g q12h post-HD | 62.9% | 70.0% | 70.6% | 70.6% | 70.6% | 70.6% | 70.6% | ||
3 | Sequential 4-hour HD & 20-hour UF | 60% fT > MIC | 2 g LD, 1 g q24h post-HD | 0.7% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% |
60% fT > MICx4 | 3 g LD, 2 g q12h post-HD | 58.4% | 65.7% | 66.2% | 66.3% | 66.3% | 66.3% | 66.3% | ||
4 | Early 9-hour PIKRT€ daily | 60% fT > MIC | 1 g q12h | 58.1% | 74.7% | 77.4% | 78.0% | 78.2% | 78.2% | 78.2% |
60% fT > MICx4 | 2 g LD, 1 g q6h | 99.9% | 99.9% | 99.9% | 99.9% | 99.9% | 99.9% | 99.9% | ||
Late 9-hour PIKRT€ daily | 60% fT > MIC | 1 g q12h | 1.6% | 16.4% | 23.2% | 25.0% | 25.6% | 25.7% | 25.8% | |
60% fT > MICx4 | 2 g LD, 1 g q6h | 81.6% | 80.3% | 80.3% | 81.3% | 80.3% | 80.3% | 80.3% | ||
5 | Extended PIKRT daily | 60% fT > MIC | 1 g q12h | 2.1% | 11.8% | 16.4% | 17.7% | 18.1% | 18.3% | 18.4% |
60% fT > MICx4 | 2 g q8h | 62.2% | 67.9% | 68.2% | 68.2% | 68.2% | 68.2% | 68.2% |